Respiratory Syncytial Virus(RSV) Rapid Test
Product Background
Human respiratory syncytial virus (HRSV)is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic
medication, palivizumab, can be employed to prevent HRSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart Defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital Malformations of the airway. Treatment is limited to supportive care (e.g.C- PAP), including oxygen therapy. In temperate climates there is an annual pid emic during the winter months. In tropical climates, infection is most common during the rainy season.
Intended use
The Respiratory Syncytial Virus(RSV) Rapid Test is an in vitro diagnostic test for the qualitative Detection of Respiratory Syncytial Virus antigens (viral fusion protein) in nasal swab, throat Swab or nasopharyngeal swab,
using the rapid immuno-chromatographic method. It is intended to aid in the rapid difffferential diagnosis of Respiratory Syncytial Virus viral infections.
Operation steps and result interpretation
POSITIVE: Two lines appear. One colored line appears in the control region©, and another Apparent colored
line in the test region(T). The shade of color may vary, but it should be Considered positive whenever there is
even faint line.
NEGATIVE: Only one colored line appears in the control region(C). No line in the test region(T). The negative
result in dictates that there are no Respiratory Syncytial Virus particles in the sample or the number of viral
particles is below the detectable range.
INVALID: There is no purple-red band in the quality control area (C).In any case, it should be retested
Product information
